Armatus Bio

Pre-clinical

Cambridge, United StatesFounded 2021armatusbio.com

Develops gene therapies for neurological disorders using novel capsid engineering and delivery technologies.

Market Cap

Private

Pipeline

—

Patents

—

Publications

—

Private Company

Total funding raised: $85M

Develops gene therapies for neurological disorders using novel capsid engineering and delivery technologies.

RNA & Gene Therapy

Total raised:$85M

Series A$75MGordonMD Global InvestmentsJan 15, 2023

Seed$10MGordonMD Global InvestmentsJun 15, 2021